Effect Of Evobrutinib, A Bruton's Tyrosine Kinase Inhibitor, On Immune Cell And Immunoglobulin Levels Over 48 Weeks In A Phase 2 Study In Relapsing Multiple SclerosisX. Montalban,J. Shaw,S. Syed,F. Dangond,E. C. Martin, R. Grenningloh,M. S. WeberMULTIPLE SCLEROSIS JOURNAL（2020）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
